ALKS
Drug Manufacturers - Specialty & Generic · Healthcare
Chief Accounting Officer
2024-02-01–present
Chief Accounting Officer
Alkermes plc. (ALKS)Equibles does not estimate personal net worth.
Get an email with a short summary when Alkermes plc. publishes a filing, an earnings call transcript or a press release.
Get ALKS alertsSamuel J. Parisi is recorded as Chief Accounting Officer at Alkermes plc. (ALKS) since February 1, 2024. Alkermes plc. reported in an 8-K filed February 5, 2024 that Samuel J. Parisi was appointed interim principal accounting officer, effective February 1, 2024. Alkermes plc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Alkermes plc. includes Blair C. Jackson (CEO, CFO and COO), Mr. Richard F. Pops (CEO), Iain M. Brown (CFO and Chief Accounting Officer) and 7 others.
“and Samuel J. Parisi, Vice President, Finance of Alkermes, Inc., as the Company’s interim principal accounting officer”
2024-02-01–present
ALKS
Drug Manufacturers - Specialty & Generic · Healthcare
Chief Accounting Officer
2024-02-01–present